Status:
COMPLETED
A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)
Lead Sponsor:
Abbott
Conditions:
Hypertension
Diabetes
Eligibility:
All Genders
40+ years
Phase:
PHASE4
Brief Summary
The BENEDICT study is conducted to examine the effects of an ACE inhibitor, calcium channel blockade, a combination of these, and placebo, in the prevention of micro- and macro-albuminuria in Type 2 d...
Eligibility Criteria
Inclusion
- Type 2 Diabetes
- Hypertension
Exclusion
- Albuminuria (Phase A)
- Non-diabetic renal disease
- Subject has a hypersensitivity to ACE inhibitor, CCB
Key Trial Info
Start Date :
March 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1204 Patients enrolled
Trial Details
Trial ID
NCT00235014
Start Date
March 1 1997
Last Update
July 15 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.